SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001437749-18-001952
Filing Date
2018-02-07
Accepted
2018-02-07 17:28:05
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avir20180207_8k.htm 425 1167601
2 EXHIBIT 2.1 ex_104594.htm EX-2.1 19511
3 EXHIBIT 2.2 ex_104595.htm EX-2.2 45478
4 EXHIBIT 99.1 ex_104596.htm EX-99.1 25351
5 b1.jpg GRAPHIC 9053
  Complete submission text file 0001437749-18-001952.txt   1272723
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filed by) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 425 | Act: 34 | File No.: 001-35285 | Film No.: 18582056
SIC: 2836 Biological Products, (No Diagnostic Substances)